Key stats
About BNP PARIBAS EASY ECPI GLOBAL ESG MED TECH UCITS ETF CAP
Home page
Inception date
Dec 10, 2021
Structure
Luxembourg SICAV
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
BNP PARIBAS ASSET MANAGEMENT Luxembourg SA
ISIN
LU2365457410
Replicate the performance of the ECPI Global ESG Medical Tech (NR) Index (Bloomberg: GALPHMTN Index), including fluctuations, and to maintain the Tracking Err between the sub-fund and the index below 1%.
Classification
Returns
1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
---|---|---|---|---|---|---|
Price performance | — | — | — | — | — | — |
NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.97%
Health Technology95.28%
Commercial Services2.50%
Technology Services2.18%
Bonds, Cash & Other0.03%
Cash0.03%
Stock breakdown by region
North America45.93%
Europe42.61%
Asia5.82%
Oceania5.64%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
MEDTE invests in stocks. The fund's major sectors are Health Technology, with 95.28% stocks, and Commercial Services, with 2.50% of the basket. The assets are mostly located in the North America region.
MEDTE top holdings are BeiGene Ltd and Eurofins Scientific SE, occupying 2.94% and 2.50% of the portfolio correspondingly.
No, MEDTE doesn't pay dividends to its holders.
MEDTE shares are issued by BNP Paribas SA under the brand BNP Paribas. The ETF was launched on Dec 10, 2021, and its management style is Passive.
MEDTE expense ratio is 0.32% meaning you'd have to pay 0.32% of your investment to help manage the fund.
MEDTE follows the ECPI Global ESG Medical Tech Index - EUR - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
MEDTE invests in stocks.
MEDTE price has risen by 7.38% over the last month, and its yearly performance shows a −5.91% decrease. See more dynamics on MEDTE price chart.
NAV returns, another gauge of an ETF dynamics, showed a −10.21% decrease in three-month performance and has decreased by −7.05% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −10.21% decrease in three-month performance and has decreased by −7.05% in a year.
MEDTE trades at a premium (1.03%) meaning the ETF is trading at a higher price than the calculated NAV.